• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Specialty Pharma

Hua Han Bio-Pharmaceutical Holdings Ltd

+ Add to Watchlist


0.236 EUR 0.005 2.16%

As of 04:55:03 ET on 09/18/2014.

Snapshot for Hua Han Bio-Pharmaceutical Holdings Ltd (HUI)

Open: 0.248 Day's Range: 0.236 - 0.248 Volume: 0
Previous Close: 0.231 52wk Range: 0.103 - 0.268 1-Yr Rtn: +85.38%

Stock Chart for HUI

No chart data available.
  • HUI:GR 0.236
  • 1D
  • 1M
  • 1Y
Interactive HUI Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for HUI

Current P/E Ratio (ttm) -
Estimated P/E(06/2014) 27.7961
Relative P/E vs. DAX -
Earnings Per Share (HKD) (ttm) -
Est. EPS (HKD) (06/2014) 0.0850
Est. PEG Ratio -
Market Cap (M EUR) 963.84
Shares Outstanding (M) 4,084.08
30 Day Average Volume 533
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 0.77%
Cash Dividend (HKD) 0.0400
Dividend Ex-Date 12/27/2013
5 Year Dividend Growth -
Next Earnings Announcement 09/29/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for HUI

  • Revenue
  • Net Income (M/HKD)
  • Profit Margin (%)

Company Profile & Key Executives for HUI

Hua Han Bio-Pharmaceutical Holdings Limited, through its subsidiaries, researches, develops, manufactures, and sells Chinese herbal pharmaceutical products primarily for women and the elderly under its Yeosure brand name. The Company also researches, develops, manufactures, and sells naturally-sourced anti-tumor medicines and western pharmaceutical products.

Zhang Peter YChairman/Co-FounderDeng JieCEO/Co-Founder
Zhang Bing ShengChief Investment SupervisorNiu YiChief Inspector:Human Resource
More Company Profile & Key Executives for HUI

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil